The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic–Therapeutic Implications
Genes · 22.11.2023 · 14 (12) · 2111
DOI: 10.3390/genes14122111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 22.11.2023. Verfasst von Giovanna Scorrano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, "G. D'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Ectodermal Dysplasia. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiofaciocutaneous (CFC) syndrome is one of the rarest RASopathies characterized by multiple congenital ectodermal, cardiac and craniofacial abnormalities with a mild to severe ocular, gastrointestinal and neurological involvement. It is an autosomal dominant syndrome, with complete penetrance, caused by heterozygous pathogenic variants in the genes BRAF, MAP2K1/MEK1, MAP2K2/MEK2, KRAS or, rarely, YWHAZ, all part of the RAS-MAPK pathway. This pathway is a signal transduction cascade that plays a crucial role in normal cellular processes such as cell growth, proliferation, differentiation, survival, metabolism and migration. CFC syndrome overlaps with Noonan syndrome, Costello syndrome, neurofibromatosis type 1 and Legius syndrome, therefore making the diagnosis challenging. Neurological involvement in CFC is more severe than in other RASopathies. Phenotypic variability in CFC patients is related to the specific gene affected, without a recognized genotype–phenotype correlation for distinct pathogenic variants. Currently, there is no specific treatment for CFC syndrome. Encouraging zebrafish model system studies suggested that, in the future, MEK inhibitors could be a suitable treatment of progressive phenotypes of CFC in children. A multidisciplinary care is necessary for appropriate medical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, "G. D'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
- Department of Translational and Precision Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
- UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
- Pediatric Nephrology and Dialysis Unit, University Hospital "G. Martino", 98124 Messina, Italy.
- Child Neuropsychiatry Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98124 Messina, Italy.
- Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina, 98122 Messina, Italy.
ORCID-Profile: Elisa Calì, Saverio La Bella, Armando Di Ludovico, Giuseppe Donato Mangano, Chiara Leoni
Zitieren
APA
Scorrano, G., David, E., Calì, E., Chimenz, R., La Bella, S., Di Ludovico, A., Di Rosa, G., Gitto, E., Mankad, K., Nardello, R., Mangano, G. D., Leoni, C., & Ceravolo, G. (2023). The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic–Therapeutic Implications. Genes, 14(12), 2111. https://doi.org/10.3390/genes14122111
Vancouver
Scorrano G, David E, Calì E, Chimenz R, La Bella S, Di Ludovico A, et al. The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic–Therapeutic Implications. Genes. 2023;14(12):2111. doi:10.3390/genes14122111
BibTeX
@article{Scorrano2023,
author = {Scorrano, Giovanna and David, Emanuele and Calì, Elisa and Chimenz, Roberto and La Bella, Saverio and Di Ludovico, Armando and Di Rosa, Gabriella and Gitto, Eloisa and Mankad, Kshitij and Nardello, Rosaria and Mangano, Giuseppe Donato and Leoni, Chiara and Ceravolo, Giorgia},
title = {The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic–Therapeutic Implications},
journal = {Genes},
year = {2023},
volume = {14},
number = {12},
pages = {2111},
doi = {10.3390/genes14122111}
}
EUVIMED